These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14962962)

  • 1. Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis.
    van Aken J; Lard LR; le Cessie S; Hazes JM; Breedveld FC; Huizinga TW
    Ann Rheum Dis; 2004 Mar; 63(3):274-9. PubMed ID: 14962962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
    de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF
    Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids.
    Sanmartí R; Gómez-Centeno A; Ercilla G; Larrosa M; Viñas O; Vazquez I; Gómez-Puerta JA; Gratacós J; Salvador G; Cañete JD
    Clin Rheumatol; 2007 Jul; 26(7):1111-8. PubMed ID: 17109060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
    Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies.
    Lard LR; Visser H; Speyer I; vander Horst-Bruinsma IE; Zwinderman AH; Breedveld FC; Hazes JM
    Am J Med; 2001 Oct; 111(6):446-51. PubMed ID: 11690569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis.
    Reneses S; González-Escribano MF; Fernández-Suárez A; Pestana L; Davila B; Wichmann I; García A
    J Rheumatol; 2009 Jun; 36(6):1143-9. PubMed ID: 19411391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage.
    Lard LR; Boers M; Verhoeven A; Vos K; Visser H; Hazes JM; Zwinderman AH; Schreuder GM; Breedveld FC; De Vries RR; van der Linden S; Zanelli E; Huizinga TW
    Arthritis Rheum; 2002 Apr; 46(4):899-905. PubMed ID: 11953965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies.
    Mustila A; Korpela M; Haapala AM; Kautiainen H; Laasonen L; Möttönen T; Leirisalo-Repo M; Ilonen J; Järvenpää S; Luukkainen R; Hannonen P
    Clin Exp Rheumatol; 2011; 29(3):500-5. PubMed ID: 21640044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis.
    Mattey DL; Hassell AB; Dawes PT; Cheung NT; Poulton KV; Thomson W; Hajeer AH; Ollier WE
    Arthritis Rheum; 2001 Jul; 44(7):1529-33. PubMed ID: 11465703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of HLA-DRB1 genes, rheumatoid factor, and treatment on radiographic disease progression in rheumatoid arthritis over 6 years.
    Rau R; Herborn G; Zueger S; Fenner H
    J Rheumatol; 2000 Nov; 27(11):2566-75. PubMed ID: 11093435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductions in Radiographic Progression in Early Rheumatoid Arthritis Over Twenty-Five Years: Changing Contribution From Rheumatoid Factor in Two Multicenter UK Inception Cohorts.
    Carpenter L; Norton S; Nikiphorou E; Jayakumar K; McWilliams DF; Rennie KL; Dixey J; Kiely P; Walsh DA; Young A;
    Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1809-1817. PubMed ID: 28217885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic markers of radiographic progression in early rheumatoid arthritis.
    Goronzy JJ; Matteson EL; Fulbright JW; Warrington KJ; Chang-Miller A; Hunder GG; Mason TG; Nelson AM; Valente RM; Crowson CS; Erlich HA; Reynolds RL; Swee RG; O'Fallon WM; Weyand CM
    Arthritis Rheum; 2004 Jan; 50(1):43-54. PubMed ID: 14730598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting.
    Sanmarti R; Gomez A; Ercilla G; Gratacos J; Larrosa M; Suris X; Vinas O; Salvador G; Munoz-Gomez J; Canete JD
    Rheumatology (Oxford); 2003 Sep; 42(9):1044-9. PubMed ID: 12730518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated prediagnosis radiological progression: an important tool for studying the effects of early disease modifying antirheumatic drug treatment in rheumatoid arthritis.
    Wick MC; Lindblad S; Weiss RJ; Klareskog L; van Vollenhoven RF
    Ann Rheum Dis; 2005 Jan; 64(1):134-7. PubMed ID: 15096329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up study.
    Quintana-Duque MA; Rondon-Herrera F; Mantilla RD; Calvo-Paramo E; Yunis JJ; Varela-Nariño A; Restrepo JF; Iglesias-Gamarra A
    Clin Rheumatol; 2016 Jun; 35(6):1463-73. PubMed ID: 27041382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of radiographic joint damage in patients with early rheumatoid arthritis.
    Jansen LM; van der Horst-Bruinsma IE; van Schaardenburg D; Bezemer PD; Dijkmans BA
    Ann Rheum Dis; 2001 Oct; 60(10):924-7. PubMed ID: 11557647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial.
    Rantalaiho V; Kautiainen H; Korpela M; Hannonen P; Kaipiainen-Seppänen O; Möttönen T; Kauppi M; Karjalainen A; Laiho K; Laasonen L; Hakola M; Peltomaa R; Leirisalo-Repo M;
    Ann Rheum Dis; 2014 Nov; 73(11):1954-61. PubMed ID: 23908187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum levels of pro-matrix metalloproteinase-3 are associated with greater radiographic damage and the presence of the shared epitope in patients with rheumatoid arthritis.
    Cheung NT; Dawes PT; Poulton KV; Ollier WE; Taylor DJ; Mattey DL
    J Rheumatol; 2000 Apr; 27(4):882-7. PubMed ID: 10782810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-month metacarpal bone mineral density loss predicts radiological joint damage progression after 1 year in patients with early rheumatoid arthritis: exploratory analyses from the IMPROVED study.
    Wevers-de Boer KV; Heimans L; Visser K; Kälvesten J; Goekoop RJ; van Oosterhout M; Harbers JB; Bijkerk C; Steup-Beekman M; de Buck MP; de Sonnaville PB; Huizinga TW; Allaart CF
    Ann Rheum Dis; 2015 Feb; 74(2):341-6. PubMed ID: 24285491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. Berlin Collaborating Rheumatological Study Group.
    Listing J; Rau R; Müller B; Alten R; Gromnica-Ihle E; Hagemann D; Zink A
    J Rheumatol; 2000 Sep; 27(9):2100-9. PubMed ID: 10990219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.